New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2012
09:12 EDTS, PBY, GALE, PCS, ESIO, TOL, DTEGY, MTN, TEVA, BIG, DRIOn The Fly: Pre-market Movers
HIGHER AFTER EARNINGS: Big Lots (BIG), up 7.3%... Toll Brothers (TOL), up 4.6%... ALSO HIGHER: Galena Biopharma (GALE), up 15% after signing NeuVax commercialization partnership with Teva (TEVA)... Electro Scientific (ESIO), up 12% after declaring $2/share special dividend... LOWER AFTER EARNINGS: Pep Boys (PBY), down 8.7%... Vail Resorts (MTN), down 7.3%... ALSO LOWER: Darden (DRI), down 8.9% after warning on Q2, FY13 EPS... MetroPCS (PCS), down 6.6% after Reuters says Sprint (S) unlikely to counter T-Mobile's (DTEGY) bid.
News For DRI;BIG;TOL;GALE;TEVA;ESIO;PBY;MTN;PCS;S;DTEGY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 15, 2015
09:31 EDTTEVAAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
08:50 EDTTOLToll Brothers downgraded to Outperform from Strong Buy at Raymond James
Raymond James downgraded Toll Brothers to Outperform and reduced its price target to $41 from $45 citing lack of catalysts to propel shares higher and valuation.
08:46 EDTDTEGYMobile operators ad blocking plan sets up fight with Google, FT reports
Subscribe for More Information
08:12 EDTTEVATeva migraine treatment data positive, says Bernstein
Subscribe for More Information
08:04 EDTTEVATeva to present new respiratory data at 2015 ATS conference
Teva Pharmaceutical Industries announced that three company-sponsored abstracts will be presented at the 2015 American Thoracic Society International Conference in Denver, Colorado on May 15-19.Data to be presented include a Phase III study examining the functionality, reliability, accuracy and overall patient satisfaction of ProAir RespiClick inhalation powder, which gained approval from the U.S. FDA in March 2015. ProAir RespiClick is now available by prescription and is indicated for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm in patients 12 years of age and older. Additional Phase III data to be presented include a late-breaking abstract highlighting an interim analysis of the long-term safety and efficacy of Teva’s investigational anti-IL-5 therapy, reslizumab, in patients with asthma and elevated blood eosinophils. A third abstract to be presented includes data from a dose-ranging study of fluticasone propionate multi-dose, dry-powder inhaler in adolescent and adult patients with asthma.
May 14, 2015
10:31 EDTST-Mobile says porting ratio vs. Sprint is approaching 3.0
In regards to LTE competition and sustainability, T-Mobile said it is in a leadership position where it really matters. Backs operating free cash flow and EBITDA guidance. Reports 11M MetroPCS subscribers. Comments taken from MoffettNathanson Media & Communications Summit.
08:35 EDTTEVATeva says data present case for TEV-48125 progression to Phase III
Subscribe for More Information
07:44 EDTTEVAInternational Headache Society to hold a conference
17th Congress of the International Headache Society is being held in Valencia, Spain on May 14-17.
06:06 EDTSDISH plans to enter wireless business, Yahoo reports
DISH (DISH) plans to enter the wireless business in an attempt to become the only provider to offer wireless voice, video and data services, Adam Samson of Yahoo Finance reports, citing an internal document. The document, marked confidential, obtained by Yahoo indicates Dish is looking to hire a chief marketing officer to help guide its move into the wireless space, Samson adds. The move comes after DISH acquired nearly half of the spectrum licenses offered in a U.S. government auction. The top U.S. wireless providers are Verizon (VZ), AT&T (T), T-Mobile (TMUS) and Sprint (S). Reference Link
May 13, 2015
15:27 EDTSStandard General acquires rights to RadioShack brand, data, WSJ says
Subscribe for More Information
08:02 EDTTEVAANI Pharmaceuticals acquires rights to testosterone gel 1%
Subscribe for More Information
May 12, 2015
16:08 EDTESIOElectro Scientific sees Q1 non-GAAP EPS (15c)-(20c), consensus (16c)
Subscribe for More Information
16:06 EDTESIOElectro Scientific reports Q4 non-GAAP EPS (21c), consensus (26c)
Subscribe for More Information
12:02 EDTSVerizon, Sprint settle illegal billing investigations for $158M
Subscribe for More Information
07:50 EDTMTNWells Fargo to hold a conference
Subscribe for More Information
May 11, 2015
14:27 EDTTEVACowen recommends adding to both Teva and Mylan at current levels
Cowen recommends adding to both Teva (TEVA) and Mylan (MYL) at current levels. The firm continues to believe that a Mylan transaction will proceed despite some early contentious language, and all of Mylan's concerns will be resolved.
11:53 EDTTEVATeva rejected chance to acquire Perrigo a few months ago, Globes reports
Subscribe for More Information
08:48 EDTDRIPanera Bread appoints Drew Madsen President effective May 11
Subscribe for More Information
06:19 EDTSRadioShack trademark, other IP up for auction, WSJ reports
Subscribe for More Information
May 10, 2015
19:25 EDTTEVACourt rejects claim that drugmakers misled opiate patients, Bloomberg says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use